NCT04904588 2026-03-18ACCESSCenter for International Blood and Marrow Transplant ResearchPhase 2 Active not recruiting300 enrolled
NCT04375631 2026-03-05CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic LeukemiaFred Hutchinson Cancer CenterPhase 1 Recruiting120 enrolled
NCT04195633 2026-02-27Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological MalignanciesFred Hutchinson Cancer CenterPhase 2 Recruiting60 enrolled
NCT05170828 2026-02-24Cryopreserved MMUD BM With PTCy for Hematologic MalignanciesOssium Health, Inc.Phase 1 Withdrawn
NCT02861417 2026-02-17Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantM.D. Anderson Cancer CenterPhase 2 Active not recruiting204 enrolled